DBV Technologies Anticipates Peanut Patch BLA Filing in Q3 2026
DBV Technologies anticipates filing its Biologics License Application for the VIASKIN Peanut Patch in children aged 4 through 7 years in Q3 2026. The company received guidance to reformat data without needing to conduct additional clinical trials.
View filing at SEC.gov →